Universiti Malaya Medical Centre
Kuala Lumpur, Kuala Lumpur, Malaysia
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
Phase 3
A Study to Learn More About How Well Sevabertinib (BAY 2927088) Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
HER2 MutationAdvanced Non-Small Cell Lung Cancer
Bayer278 enrolled283 locationsNCT06452277
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Chronic Obstructive Pulmonary Disease
Upstream Bio Inc.666 enrolled325 locationsNCT06981078
Recruiting
Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Mutations
Non-Small Cell Lung Carcinoma (NSCLC)
University of Malaya150 enrolled4 locationsNCT07369596
Recruiting
Not Applicable
Dietary Modification In Inflammatory Bowel Disease Patients
Crohn Disease
University of Malaya74 enrolled1 locationNCT06871267
Recruiting
Not Applicable
Impact of PErioperative Nutrition Intervention on Bioimpedance Phase Angle (IPENIPA) In Breast Cancer Patients
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Mastectomy Patient
University of Malaya114 enrolled1 locationNCT06890221